JAMA Clinical Reviews podcast

Review of Cardiac Resynchronization Therapy

0:00
19:57
Rewind 15 seconds
Fast Forward 15 seconds

Heart failure (HF) affects more than 64 million individuals worldwide, and 20% to 30% of patients with HF and systolic dysfunction have cardiac dyssynchrony due to conduction system disease. JAMA Review author Mihail Chelu, MD, PhD, of Baylor College of Medicine discusses cardiac resynchronization therapy with JAMA Associate Editor David Simel, MD, MHS.

Related Content:

More episodes from "JAMA Clinical Reviews"